Abstract
Correction for ‘Effect of heterocycle content on metal binding isostere coordination’ by Benjamin L. Dick et al., Chem. Sci., 2020, 11, 6907–6914, DOI: 10.1039/D0SC02717K.
The authors regret that a complete Conflicts of interest section was not shown in the original article. The correct Conflicts of interest section is shown below.
Conflicts of interest
The authors declare the following competing financial interest(s): S. M. C. is a co-founder of and has an equity interest in Cleave Therapeutics, Forge Therapeutics, and Blacksmith Medicines, companies that may potentially benefit from the research results. S. M. C. also serves on the Scientific Advisory Board for Blacksmith Medicines and serves on the Scientific Advisory Board and receives compensation from Forge Therapeutics. The terms of this arrangement have been reviewed and approved by the University of California, San Diego in accordance with its conflict of interest policies.
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.